MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a chronic neurodegenerative illness and a leading cause of dementia, marked by selective death of neurons and impairment of cognition brought on by the buildup of amyloid β (Aβ) protein plaque and hyperphosphorylated tau proteins [1].